RU2200153C2 - Аминобензофеноны, способ их получения, фармацевтический препарат, способ лечения и профилактики воспалительных заболеваний кожи - Google Patents

Аминобензофеноны, способ их получения, фармацевтический препарат, способ лечения и профилактики воспалительных заболеваний кожи Download PDF

Info

Publication number
RU2200153C2
RU2200153C2 RU99118221/04A RU99118221A RU2200153C2 RU 2200153 C2 RU2200153 C2 RU 2200153C2 RU 99118221/04 A RU99118221/04 A RU 99118221/04A RU 99118221 A RU99118221 A RU 99118221A RU 2200153 C2 RU2200153 C2 RU 2200153C2
Authority
RU
Russia
Prior art keywords
aminophenylamino
compound
benzophenone
nmr
amino
Prior art date
Application number
RU99118221/04A
Other languages
English (en)
Russian (ru)
Other versions
RU99118221A (ru
Inventor
Эрик Рюттер Оттосен
Шнойр РАХЛИН
Original Assignee
Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) filed Critical Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб)
Publication of RU99118221A publication Critical patent/RU99118221A/ru
Application granted granted Critical
Publication of RU2200153C2 publication Critical patent/RU2200153C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU99118221/04A 1997-01-24 1998-01-08 Аминобензофеноны, способ их получения, фармацевтический препарат, способ лечения и профилактики воспалительных заболеваний кожи RU2200153C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones
GB9701453.4 1997-01-24

Publications (2)

Publication Number Publication Date
RU99118221A RU99118221A (ru) 2001-06-27
RU2200153C2 true RU2200153C2 (ru) 2003-03-10

Family

ID=10806523

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99118221/04A RU2200153C2 (ru) 1997-01-24 1998-01-08 Аминобензофеноны, способ их получения, фармацевтический препарат, способ лечения и профилактики воспалительных заболеваний кожи

Country Status (19)

Country Link
US (1) US6313174B1 (cg-RX-API-DMAC10.html)
EP (1) EP0966424B1 (cg-RX-API-DMAC10.html)
JP (1) JP4250204B2 (cg-RX-API-DMAC10.html)
KR (1) KR100544046B1 (cg-RX-API-DMAC10.html)
CN (1) CN1188388C (cg-RX-API-DMAC10.html)
AT (1) ATE269844T1 (cg-RX-API-DMAC10.html)
AU (1) AU733561B2 (cg-RX-API-DMAC10.html)
CA (1) CA2278798C (cg-RX-API-DMAC10.html)
DE (1) DE69824705T2 (cg-RX-API-DMAC10.html)
DK (1) DK0966424T3 (cg-RX-API-DMAC10.html)
ES (1) ES2223116T3 (cg-RX-API-DMAC10.html)
GB (1) GB9701453D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0000678A3 (cg-RX-API-DMAC10.html)
NZ (1) NZ336754A (cg-RX-API-DMAC10.html)
PL (1) PL334806A1 (cg-RX-API-DMAC10.html)
PT (1) PT966424E (cg-RX-API-DMAC10.html)
RO (1) RO120195B1 (cg-RX-API-DMAC10.html)
RU (1) RU2200153C2 (cg-RX-API-DMAC10.html)
WO (1) WO1998032730A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277889T1 (de) * 1999-07-16 2004-10-15 Leo Pharma As Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
KR20020022774A (ko) * 1999-07-16 2002-03-27 룬딩 에른스트 IL-1β 및 TNF-α 억제제로서의 아미노벤조페논
PT1210320E (pt) * 1999-07-16 2005-01-31 Leo Pharma As Aminobenzofenonas como inibidores de il-1beta e tnf-alfa
RU2247719C2 (ru) * 1999-07-16 2005-03-10 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний
ES2204639T3 (es) * 1999-07-16 2004-05-01 Leo Pharma A/S Nuevas aminobenzofeonas.
US6897236B1 (en) 1999-07-16 2005-05-24 Leo Pharmaceutical Products, Ltd. Aminobenzophenones as inhibitors of IL-1β and TNF-α
KR20020071876A (ko) * 1999-12-06 2002-09-13 레오 파마 에이/에스 IL-1β 및 TNF-α의 억제제로서의 아미노벤조페논
CA2393027A1 (en) * 1999-12-17 2001-06-21 Abbott Laboratories Inhibitors of interleukin 5 gene expression
CA2396693A1 (en) * 1999-12-28 2001-07-05 Stephen T. Wrobleski Cytokine, especially tnf-alpha, inhibitors
CN1239485C (zh) * 2000-05-22 2006-02-01 里奥制药有限公司 作为IL-1β和TNF-α抑制剂的二苯酮类
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
US20030073832A1 (en) * 2001-04-10 2003-04-17 Havez Sophie Elisabeth Novel aminophenyl ketone derivatives
JP4540984B2 (ja) * 2001-08-28 2010-09-08 レオ ファーマ アクティーゼルスカブ 新規アミノベンゾフェノン
RU2005122951A (ru) * 2002-12-20 2006-01-27 Лео Фарма А/С (Dk) Новые аминобензофеноновые соединения
RU2396250C2 (ru) 2003-07-24 2010-08-10 Лео Фарма А/С Новые производные аминобензофенона
EP1828148B1 (en) 2004-12-13 2010-01-20 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
KR101057546B1 (ko) * 2007-06-05 2011-08-17 주식회사 엘지화학 광학 이방성 화합물 및 이를 포함하는 수지 조성물
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
WO2012167133A2 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Inhibitors of anandamide transport and their therapeutic uses
JP6092870B2 (ja) 2011-08-19 2017-03-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア メタ置換ビフェニル末梢に限局されたfaah阻害剤
ES2908240T3 (es) 2014-04-07 2022-04-28 Univ California Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
DE3739402C2 (de) * 1986-11-21 1989-01-12 Ricoh Kk Faerbende phthalid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende aufzeichnungsmaterialien

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
DE3739402C2 (de) * 1986-11-21 1989-01-12 Ricoh Kk Faerbende phthalid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende aufzeichnungsmaterialien

Also Published As

Publication number Publication date
JP4250204B2 (ja) 2009-04-08
DE69824705D1 (de) 2004-07-29
CN1188388C (zh) 2005-02-09
JP2001511771A (ja) 2001-08-14
KR100544046B1 (ko) 2006-01-23
AU5478198A (en) 1998-08-18
NZ336754A (en) 2001-03-30
KR20000070437A (ko) 2000-11-25
DE69824705T2 (de) 2005-07-07
HUP0000678A3 (en) 2001-11-28
EP0966424B1 (en) 2004-06-23
EP0966424A1 (en) 1999-12-29
HUP0000678A2 (hu) 2001-10-28
PT966424E (pt) 2004-09-30
RO120195B1 (ro) 2005-10-28
AU733561B2 (en) 2001-05-17
CA2278798A1 (en) 1998-07-30
HK1025306A1 (en) 2000-11-10
PL334806A1 (en) 2000-03-13
WO1998032730A1 (en) 1998-07-30
ATE269844T1 (de) 2004-07-15
CN1248966A (zh) 2000-03-29
US6313174B1 (en) 2001-11-06
DK0966424T3 (da) 2004-11-01
GB9701453D0 (en) 1997-03-12
CA2278798C (en) 2007-07-03
ES2223116T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
JP4250204B2 (ja) インターロイキンおよびtnfの阻害剤としてのアミノベンゾフェノン類
KR100395280B1 (ko) 신규한3환성화합물및그를함유하는의약조성물
US6262112B1 (en) Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
JP3894949B2 (ja) 抗アテローム性動脈硬化症ジアリール化合物
US6555710B1 (en) Aminobenzophenones as inhibitors of IL-1 β and TNF-α
JP4571863B2 (ja) 抗痛覚過敏剤として有用なキナゾリノン誘導体
EP0617010B1 (en) Therapeutic compounds
HUP0201846A2 (en) Amonobenzophenones as inhibitors of il-1betha and tnf-alpha and pharmaceutical compositions containing them
RU2240995C2 (ru) Аминобензофеноны в качестве ингибиторов интерлейкина il-1бета и фактора некроза опухолей tnf-альфа
US6750253B1 (en) Aminobenzophenones as inhibitors of il-1β and tnf-α
RS50886B (sr) Nova jedinjenja koja su jaki inhibitori mehanizma za izmenu na+/ca2+ i korisni su kod lečenja aritmija
EP3611158A1 (en) 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
US20090105327A1 (en) Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
CZ259899A3 (cs) Aminobenzofenony jako inhibitory interleukinu a TNF
EP0924202B1 (en) Imidazole derivative and medicine comprising the same as active ingredient
US6897236B1 (en) Aminobenzophenones as inhibitors of IL-1β and TNF-α
Kukolja et al. Substances Acting on the Central Nervous System. IV. Derivatives of 2-Ethyl-2-phenylbutyramide
JPWO2001016091A1 (ja) ビスシクロプロパンカルボン酸アミド化合物およびその医薬用途

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130109